Zobrazeno 1 - 10
of 149
pro vyhledávání: '"Susana Ros"'
Autor:
Lorna Hopcroft, Eleanor M. Wigmore, Stuart C. Williamson, Susana Ros, Cath Eberlein, Jennifer I. Moss, Jelena Urosevic, Larissa S. Carnevalli, Sara Talbot, Lauren Bradshaw, Catherine Blaker, Sreeharsha Gunda, Venetia Owenson, Scott Hoffmann, Daniel Sutton, Stewart Jones, Richard J. A. Goodwin, Brandon S. Willis, Claire Rooney, Elza C. de Bruin, Simon T. Barry
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-14 (2023)
Abstract Combining the selective AKT inhibitor, capivasertib, and SERD, fulvestrant improved PFS in a Phase III clinical trial (CAPItello-291), treating HR+ breast cancer patients following aromatase inhibitors, with or without CDK4/6 inhibitors. How
Externí odkaz:
https://doaj.org/article/216706db2e6b4b6eae15d98244910c27
Autor:
Lorna Hopcroft, Eleanor M. Wigmore, Stuart C. Williamson, Susana Ros, Cath Eberlein, Jennifer I. Moss, Jelena Urosevic, Larissa S. Carnevalli, Sara Talbot, Lauren Bradshaw, Catherine Blaker, Sreeharsha Gunda, Venetia Owenson, Scott Hoffmann, Daniel Sutton, Stewart Jones, Richard J. A. Goodwin, Brandon S. Willis, Claire Rooney, Elza C. de Bruin, Simon T. Barry
Publikováno v:
npj Breast Cancer, Vol 9, Iss 1, Pp 1-1 (2023)
Externí odkaz:
https://doaj.org/article/597341a4bba64230b85546c506522cc0
Autor:
Flaviu Bulat, Friederike Hesse, De-En Hu, Susana Ros, Connor Willminton-Holmes, Bangwen Xie, Bala Attili, Dmitry Soloviev, Franklin Aigbirhio, Finian. J. Leeper, Kevin M. Brindle, André A. Neves
Publikováno v:
EJNMMI Research, Vol 10, Iss 1, Pp 1-14 (2020)
Abstract Introduction Trialing novel cancer therapies in the clinic would benefit from imaging agents that can detect early evidence of treatment response. The timing, extent and distribution of cell death in tumors following treatment can give an in
Externí odkaz:
https://doaj.org/article/e21d4f55168b4903adafd4356cd7f69c
Autor:
José Luis Muñoz de Nova, Guzmán Franch-Arcas, Gina Paola Mejía-Abril, María Eugenia Flores-Ruiz, Nuria Muñoz-Pérez, Elena Pintos-Sánchez, Francisco Javier Guadarrama González, Álvaro Valdés de Anca, Enrique Mercader-Cidoncha, Aitor de la Quintana-Basarrate, Irene Osorio-Silla, Susana Ros-López, Lander Gallego-Otaegui, Elena Santos-Molina, Concepción Martínez-Nieto, Elena Gamborino-Caramés, Mariano Artés-Caselles, Leyre Lorente-Poch, Maitane García-Carrillo, Pablo Moreno-Llorente, Consuelo Marín-Velarde, Joaquín Ortega-Serrano, Juan Manuel Martos-Martínez, Oscar Vidal-Pérez, Patricia Luengo-Pierrard, Jesús María Villar-del-Moral
Publikováno v:
Contemporary Clinical Trials Communications, Vol 22, Iss , Pp 100806- (2021)
Background: Currently, both the American Thyroid Association and the European Thyroid Association recommend preoperative preparation with Lugol's Solution (LS) for patients undergoing thyroidectomy for Graves’ Disease (GD), but their recommendation
Externí odkaz:
https://doaj.org/article/bbad96197cd743c786594d3899ca1b54
Autor:
Jorge Sánchez, Ana García, José María Ruiz, Ana María Montes, Juan Cabezas-Herrera, Susana Ros-Lara, Ernesto De la Cruz, Ana María Gutiérrez
Publikováno v:
Frontiers in Veterinary Science, Vol 6 (2019)
In this study, the influence of several factors such as breed, sex, and production stage over the normal range values of salivary biomarkers of health status was evaluated in pigs. A total of 409 pigs of 2 different breeds (conventional Large White
Externí odkaz:
https://doaj.org/article/4c1ee7a83401434b91f02ada6999ff15
Fracaso renal agudo secundario a crisis de hipercalcemia muy severa por hiperparatiroidismo primario
Autor:
Andrea Chacón, Ana Vilar, David Arroyo, Felipe Sarró, Lourdes Craver, Susana Ros, Carolina López, Alex Castillo, Xavier Matías-Guiu, Elvira Fernández-Giráldez
Publikováno v:
Nefrología, Vol 35, Iss 2, Pp 224-226 (2015)
Externí odkaz:
https://doaj.org/article/ec0f08e941294a6e95607ea53b67aed6
Autor:
Andrea Chacón, Ana Vilar, David Arroyo, Felipe Sarró, Lourdes Craver, Susana Ros, Carolina López, Alex Castillo, Xavier Matías-Guiu, Elvira Fernández-Giráldez
Publikováno v:
Nefrología (English Edition), Vol 35, Iss 2, Pp 224-226 (2015)
Externí odkaz:
https://doaj.org/article/17953cdbd2024ae682705907442d7ee0
Autor:
Baena Fustegueras, Juan Antonio, González, Fernando Herrerías, Calderó, Sònia Gatius, de la Fuente Juárez, Ma Cruz, López, Susana Ros, Riu, Ferran Rius, Petit, Núria Mestres, Álvarez, Pablo Muriel, Torelló, Albert Lecube, Matias-Guiu, Xavier, Olsina Kissler, Jorge Juan
Publikováno v:
In European Journal of Surgical Oncology July 2019 45(7):1175-1181
Autor:
Larissa Carnevalli, Susana Ros, Jelena Urosevic, Natalie Cureton, Sophie Darcy, Mandy Lawson, Stuart Williamson, Pablo Morentin Gutierrez, Azadeh Bashi, Jennifer Moss, Christopher Morrow, Barry Simon, Teresa Klinowska
Publikováno v:
Cancer Research. 83:PD10-04
Next-generation oral selective estrogen receptor degraders (ngSERDs) are aiming to become the backbone endocrine therapy (ET) for patients with estrogen receptor positive (ER+) breast cancer (BC) by achieving greater ER signaling blockade than curren
Autor:
Almut Schulze, Nicola Zamboni, Michael Howell, Gavin Kelly, Franziska Baenke, Sofia Moco, Claudio R. Santos, Susana Ros
PDF file - 542K
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::730f98d753b5d08e5d7b22266dbdf69c
https://doi.org/10.1158/2159-8290.22528409
https://doi.org/10.1158/2159-8290.22528409